Myriad Genetics (MYGN) Reports In-Line Q2 EPS, misses on revenue, provides guidance
Go back to Myriad Genetics (MYGN) Reports In-Line Q2 EPS, misses on revenue, provides guidance| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.14 +0.28 (7.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.86 | 52 Week High | $45.34 | |||
| Open | $3.88 | 52 Week Low | $15.92 | |||
| Day High | $4.17 | P/E | 1.78 | |||
| Day Low | $3.75 | EPS | $2.33 | |||
| Volume | 2,830,710 | |||||
